Barr Pharmaceuticals, Inc.Montvale, NJ, United States (NYSE: BRL)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Barr Pharmaceuticals Financial Statements

Barr Pharmaceuticals Financial Information

Company Type Public
Headquarters
Fiscal Year-End December
Annual Report Company Web Site
Investor Relations Company Web Site
Edgar Online logo
This data is provided as per license from EDGAR Online

Barr Pharmaceuticals Income Statement

  2007 2006+ 2006
Revenue ($ mil.) 2,500.6 916.4 1,314.5
Gross Profit ($ mil.) 1,329.5 541.1 962.3
Operating Income ($ mil.) 312.6 (214.8) 487.4
Total Net Income ($ mil.) 128.4 (338.2) 336.5
Diluted EPS (Net Income) 1.18 (3.18) 3.12
  • + Fiscal Year-End Change
More Barr Pharmaceuticals financial information

Barr Pharmaceuticals Quarterly Statements

  Quarter Ending Jun 08 Quarter Ending Mar 08 Quarter Ending Dec 07
Revenue ($ mil.) 779.0 608.0 668.7
Gross Profit ($ mil.) 426.0 333.0 342.3
Operating Income ($ mil.) 124.0 75.0 74.0
Total Net Income ($ mil.) 57.0 23.0 32.5
Diluted EPS (Net Income) 0.52 0.21 0.30
More Barr Pharmaceuticals financial information

Barr Pharmaceuticals Stock Quote & Chart

09/05/08 15:01:37 EST • NYSE • 67.62 • Decreased by -0.0800 • Decreased by -0.1182 %
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
Detailed QuoteInteractive Stock Chart

Barr Pharmaceuticals Financial Ratios

  Company Industry
Median		 Market
Median1
Price/Sales Ratio 2.90 3.75 1.56
Price/Earnings Ratio 51.52 16.34 15.82
Price/Book Ratio 3.55 2.92 1.52
Price/Cash Flow Ratio 20.71 13.17 9.88
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.

Detailed Barr Pharmaceuticals Financial Ratios

Barr Pharmaceuticals Competitive Intelligence

Mylan Labs Teva Pharmaceuticals Watson Pharmaceuticals
Annual Sales ($ mil.) 1,611.8 9,408.0 2,496.6
Employees -- -- 56,400
Market Cap ($ mil.) 4,177.4 -- 3,081.3

Competitive Landscape